Levels of lipid peroxidation in human plasma and erythrocytes: Comparison between fatty acids and cholesterol

Lipids

Volumn 42, Issue 5, 2007, Pages 439-449

  Yoshida, Yasukazu ^a   Saito, Yoshiro ^a   Hayakawa, Mieko ^a   Habuchi, Yoko ^a   Imai, Yasuharu ^b   Sawai, Yoshiyuki ^b   Niki, Etsuo ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b IKEDA MUNICIPAL HOSPITAL   (Japan)

Author keywords

Antioxidant; Coenzyme Q10; Oxidative stress; Total 7 hydroxycholesterol; Total 8 iso prostaglandin F 2 ; Total hydroxyoctadecadienoic acid

Indexed keywords

ERYTHROCYTES; TOTAL 7-HYDROXYCHOLESTEROL; TOTAL HYDROXYOCTADECADIENOIC ACID; TOXIC COMPOUNDS;

CHOLESTEROL; COENZYMES; FATTY ACIDS; OXIDATION; PLASMA (HUMAN); POTASSIUM COMPOUNDS; TOXIC MATERIALS;

LIPIDS;

7BETA HYDROXYCHOLESTEROL; 8 ISOPROSTAGLANDIN F2 ALPHA; HYDROXYOCTADECADIENOIC ACID; LINOLEIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE MARKER; ERYTHROCYTE KINETICS; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; IN VIVO STUDY; LIPID PEROXIDATION; MALE; METABOLIC REGULATION; NORMAL HUMAN; OXIDATIVE STRESS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BIOLOGICAL MARKERS; CHOLESTEROL; ERYTHROCYTES; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; HYDROXYCHOLESTEROLS; LIPID PEROXIDATION; MALE; MIDDLE AGED; OXIDATION-REDUCTION;

EID: 34249883935     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-007-3037-5     Document Type: Article

References (41)

1. Niki E, Yoshida Y, Saito Y, Noguchi N (2005) Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem Biophys Res Commun 338:668-676
2. Leonarduzzi G, Arkan MC, Basaga H, Chiarpotto E, Sevanian A, Poli G (2000) Lipid oxidation products in cell signaling. Free Rad Biol Med 28:1370-1378
3. Ceaser EK, Moellering DR, Shiva S, Ramachandran A, Landar A, Venkartraman A, Crawford J, Patel R, Dickinson DA, Ulasova E, Ji S, Darley-Usmar VM (2004) Mechanisms of signal transduction mediated by oxidized lipids: the role of the electrophile-responsive proteome. Biochem Soc Trans 32:151-155
4. Chen ZH, Saito Y, Yoshida Y, Sekine A, Noguchi N, Niki E (2005) 4-Hydroxynonenal induces adaptive response and enhances PC12 celltolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J Biol Chem 51:41921-41927
5. Chen ZH, Yoshida Y, Saito Y, Sekine A, Noguchi N, Niki E (2006) Induction of adaptive response and enhancement of PC12 cell tolerance by 7-hydroxycholesterol and 15-deoxy-delta-prostaglandin J2 through up-regulation of cellular glutathione by different mechanisms. J Biol Chem 281:14440-14445
6. Gao L, Wang J, Sekhar KR, Yin H, Yared NF, Schneider SN, Sasi S, Dalton TP, Anderson ME, Chan JY, Morrow JD, Freeman ML (2007) Novel N-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between keap1 and cullin3. J Biol Chem 282:2529-2537
7. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ II (1990) A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87:9383-9387
8. Musiek ES, Yin H, Milne GL, Morrow JD (2005) Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids 40:987-994
9. Yoshida Y, Niki E (2004) Detection of lipid peroxidation in vivo: total hydroxyoctadecadienoic acid and 7-hydroxycholesterol as oxidative stress marker. Free Rad Res 38:787-794
10. Porter NA, Caldwell SE, Mills KA (1995) Mechanisms of free radical oxidation of unsaturated lipids. Lipids 30:277-290
11. Pikuleva IA (2006) Cholesterol-metabolizing cytochromes P450. Drug Metab Dispos 34:513-520
12. Smith LL, Johnson BH (1989) Biological activies of oxysterols. Free Rad Biol Med 7:285-332
13. Saito Y, Watanabe Y, Saito E, Honjoh T, Takahashi K (2001) Production and application of monoclonal antibodies to human selenoprotein P. J Health Sci 47:346-352
14. Barclay LRC, Vinqvist MR, Antunes F, Pinto RE (1997) Antioxidant activity of vitamin E determined in a phospholipid membrane by product studies: avoiding chain transfer reactions by vitamin E radicals. J Am Chem Soc 119:5764-5765
15. Noguchi N, Numano R, Kaneda H, Niki E (1998) Oxidation of lipids in low density lipoprotein particles. Free Rad Res 29:43-52
16. Sevanian A, Seraglia R, Traldi P, Rossato P, Ursini F, Hodis H (1994) Analysis of plasma cholesterol oxidation products using gas- and high-performance liquid chromatography/mass spectrometry. Free Rad Biol Med 17:397-409
17. Brown AJ, Jessup W (1999) Oxysterols and atherosclerosis. Atherosclerosis 142:1-28
18. Diczfalusy U (2004) Analysis of cholesterol oxidation products in biological samples. J AOAC Int 87:467-473
19. BjÖkhem I, Reihner E, Angelin B, Ewerth S, Akerlund JE, Einarsson K (1987) On the possible use of the serum level of 7α-hydroxycholesterol as a marker for increased activity of the cholesterol 7α-hydroxylase in humans. J Lipid Res 28:889-894
20. Schweizer RA, Zurcher M, Balazs Z, Dick B, Odermatt A (2004) Rapid hepatic metabolism of 7-ketocholesterol by 11 beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme. J Biol Chem 279:18415-18424
21. Hult M, Elleby B, Shafqat N, Svensson S, Rane A, Jornvall H, Abrahmsen L, Oppermann U (2004) Human and rodent type 11 beta-hydroxysteroid dehydrogenases are 7beta-hydroxycholesterol dehydrogenases involved in oxysterol metabolism. Cell Mol Life Sci 61:992-999
22. Arampatzis S, Kadereit B, Schuster D, Balazs Z, Schweizer RA, Frey FJ, Langer T, Odermatt A (2005) Comparative enzymology of 11 beta-hydroxysteroid dehydrogenase type 1 from six species. J Mol Endocrinol 35:89-101
23. Thomas JP, Maiorino M, Ursini F, Girotti AW (1990) Protective action of phospholipid hydroperoxide glutathione peroxidase against membrane-damaging lipid peroxidation. In situ reduction of phospholipid and cholesterol hydroperoxides. J Biol Chem 265:454-461
24. Kühn H, Borchert A (2002) Regulation of enzymatic lipid peroxidation: the interplay of peroxidation and peroxide reducing enzymes. Free Rad Biol Med 33:154-172
25. Kühn H, Heydeck D, Hugou I, Gniwotta C (1997) In vivo action of 15-lipoxygenase in early stages of human atherogenesis. J Clin Invest 99:888-893
26. Yamashita H, Nakamura A, Noguchi N, Niki E, Kühn H (1999) Oxidation of low density lipoprotein and plasma by 15-lipoxygenase and free radicals. FEBS Lett 445:287-290
27. Dufour C, Loonis M (2005) Regio- and stereoselective oxidation of linoleic acid bound to serum albumin: identification by ESI-mass spectrometry and NMR of the oxidation products. Chem Phys Lipids 138:60-68
28. Niki E, Yamamoto Y, Takahashi M, Yamamoto K, Yamamoto Y, Komuro E, Miki M, Yasuda H, Mino M (1988) Free-radical mediated damage of blood and its inhibition by antioxidants. J Nutr Sci Vitaminol 34:507-512
29. 4 poisoning? Free Rad Biol Med 38:698-710
30. Kadiiska MB, Gladen BC, Baird DD, Graham LB, Parker CE, Ames BN, Basu S, FitzGerald GA, Lawson JA, Marnett LJ, Morrow JD, Murray DM, Plastaras J, Roberts II LJ, Rokach J, Shigenaga MK, Sun J, Walter PB, Tomer KB, Barrett JC, Mason RP (2005) Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Rad Biol Med 38:711-718
31. Yoshida Y, Itoh N, Hayakawa M, Piga R, Cynshi O, Jishage K, Niki E (2005) Lipid peroxidation induced by carbon tetrachloride and its inhibition by antioxidant as evaluated by an oxidative stress marker, HODE. Toxicol Appl Pharmacol 208:87-97
32. Yoshida Y, Itoh N, Hayakawa M, Habuchi Y, Inoue R, Chen ZH, Cao J, Cynshi O, Niki E (2006) Lipid peroxidation in mice fed choline-deficient diet and its inhibition by antioxidants as evaluated by an oxidative stress marker, HODE. Nutrition 22:303-311
33. 2α. Neurosci Lett 398:63-68
34. Yoshida Y, Hayakawa M, Niki E (2005) Total hydroxyoctadecadienoic acid as a marker for lipid peroxidation in vivo. BioFactors 24:7-15
35. Yoshida Y, Hayakawa M, Habuchi Y, Niki E (2006) Evaluation of the dietary effects of coenzyme Q in vivo by the oxidative stress marker, hydroxyoctadecadienoic acid and its stereoisomer ratio. Biochim Biophys Acta 1760:1558-1568
36. 2α. Anal Chim Acta 585:86-93
37. Kalen A, Appelkvist EL, Dallner G (1989) Age-related changes in the lipid compositions of rat and human tissues. Lipids 24:579-584
38. Komorowski J, Muratsu K, Nara Y, Willis R, Folkers K (1988) Significance of biological parameters of human blood levels of CoQ10. BioFactors 1:67-69
39. Zita C, Overvad K, Mortensen SA, Sindberg CD, Moesgaard S, Hunter DA (2003) Serum coenzyme Q10 concentrations in healthy men supplemented with 30 mg or 100 mg coenzyme Q10 for two months in a randomised controlled study. BioFactors 18:185-193
40. 10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults. Clin Chim Acta 332:123-132
41. Kaikkonen J, Kosonen L, Nyyssonen K, Ristonmaa U, Salonen JT (1998) Effect of combined coenzyme Q10 and d-α-tocopheryl acetate supplementation on exercise-induced lipid peroxidation and muscular damage: a placebo-controlled double-blind study in marathon runners. Free Rad Res 29:85-92